BlackRock Investment Management’s Molecular Templates, Inc. MTEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-1,395
Closed -$106K 4155
2016
Q1
$106K Buy
1,395
+19
+1% +$1.12K ﹤0.01% 3234
2015
Q4
$109K Buy
1,376
+12
+0.9% +$5.92K ﹤0.01% 3274
2015
Q3
$916K Buy
1,364
+4
+0.3% +$2.85K ﹤0.01% 2662
2015
Q2
$906K Buy
1,360
+319
+31% +$211K ﹤0.01% 2845
2015
Q1
$698K Buy
1,041
+103
+11% +$67.8K ﹤0.01% 2781
2014
Q4
$492K Buy
938
+6
+0.6% +$3K ﹤0.01% 3027
2014
Q3
$555K Buy
932
+16
+2% +$11.1K ﹤0.01% 2910
2014
Q2
$598K Buy
916
+112
+14% +$74.2K ﹤0.01% 2944
2014
Q1
$631K Buy
804
+4
+0.5% +$3.25K ﹤0.01% 2824
2013
Q4
$616K Sell
800
-14
-2% -$10.6K ﹤0.01% 2849
2013
Q3
$625K Buy
814
+52
+7% +$42.7K ﹤0.01% 2777
2013
Q2
$661K Buy
+762
New +$644K ﹤0.01% 2658

Other funds holding MTEM

BlackRock Investment Management's MTEM Position: Q2 2016 in Review

BlackRock Investment Management sold out of Molecular Templates, Inc. (MTEM) in Q2 2016, closing a stake of 1,395 shares — an estimated $106K sold.

BlackRock Investment Management first reported a position in MTEM in Q2 2013 and held it in 12 quarters. The position peaked at $916K in Q3 2015. 60 funds tracked by Wall St. Rank hold MTEM as of Q2 2016.

  • BlackRock Investment Management reported no remaining Molecular Templates, Inc. position as of Q2 2016 after selling out during the quarter.
  • BlackRock Investment Management sold 1,395 Molecular Templates, Inc. shares in Q2 2016, an estimated $106K.
  • BlackRock Investment Management first reported a position in Molecular Templates, Inc. in Q2 2013 and held it in 12 quarters.
  • BlackRock Investment Management's Molecular Templates, Inc. position peaked at $916K in Q3 2015.
  • 60 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q2 2016.

Based on BlackRock Investment Management's 13F filing for Q2 2016, filed 10 Aug 2016.